throbber
1 of 4
`
`MILLENIUM EXHIBIT 2016
`Baxter Healthcare Corp. et. al. v. Millenium Biologix, LLC
`IPR2013-00582,-00583,-00590,-00591
`
`

`

`Toxicity of silica-containing glass: M. Nagase et al.
`
`173
`
`taneously and were dosed intraperitoneally from the
`same single glass stock suspensions.
`
`IOO Ca (P03)2 to X Sio2
`x
`
`(pmoI/cma)
`
`Dissolved
`
`(.‘.a(P03)2
`
`0.|
`
`0.2
`Molar fraction
`
`Figure 2 Amount of dissolved ions in water at 37°C for 50 h
`versus. glass composition. The dissolution of ions into the
`water depended on the glass composition. (0) P5“;
`([1)
`Ca2+;(A) Si“.
`
`Effect of particle measurements
`
`The differences in grain sizes or surface areas among
`samples did not affect the amounts of dissolved ions from
`the samples. The diameters of grains of materials used in
`this experiment were 3.9—3.3 ,um [Table 1]. The surface areas
`of the materials were 2.3—3.2 mZ/g. except for the pure
`silica glass itself, which was 13.0 mzlg ['Rable 1).
`
`DISCUSSION
`
`Silicon is, next to oxygen, the most abundant element in
`the earth’s crust. Although only trace amounts appear in
`most animal tissues, silicon is an essential element in the
`chick‘5 and the rat7, required for normal growth and
`development. Silicon may function as a biological cross-
`linking agent and contribute to the architecture and
`resilience of connective tissue“. The ingestion of a small
`amount of amorphous silica (silicon dioxide] powder
`appears to be completely harmless, However, when
`
`Table 1 Grain sizes and surface areas
`
`
`
` Materials‘ Grain sizes (,u m) Surface areas (mZ/g)
`
`
`
`Quantitative determination of dissolved ions
`
`The amount of dissolved Si“, Ca2+ and P5+ from the
`glass specimen in water was quantitatively determined
`using an inductively coupled plasma [ICP] analyser
`[Shimadzu, [CPS-500). A plate—like specimen of a sample
`of glass [surface area = 2 cm2] was used. The dissolved
`ions were determined after immersing the specimen in
`300 ml of distilled water at 37°C for 50 h.
`
`RESULTS
`
`Mortality
`
`Intraperitoneal administration of calcium phosphate
`glass containing various concentrations of silica resulted
`in an increase in the mortality with increasing amounts
`of silica in the glass. The mortality was 0/10, 3/10, 9/10,
`10/10 and 10/10 at X = O, 5, 10, 15 and 40 mol of silica,
`respectively [Figure 1]. The mean time of death was 68.0,
`29.3. 19.2 and 6.0 h after treatment at x = 5, 10, 15 and
`40 mol of silica. respectively [Figure 1]. The mortality in
`mice given pure silica glass powder itself was 0/10. In
`contrast to the mortality with silica glass itself or calcium
`phosphate glass without silica, the silica in calcium
`phosphate glass decreased the mean time of death and
`increased the number of deaths within 30 days.
`
`Quantitative determination of dissolved ions
`The dissolved amount of Si“, Ca2+ and P5+ in the water
`from the calcium phosphate glasses increased with the
`increasing amount of silica in the glass (Figure 2). No
`dissolved Si“, Ca2+ or P5+ was detected by ICP after
`50 h of treatment of pure silica glass [SiOzz molar
`fraction = 1] in water.
`
`l
`
`
`
`010
`
`
`
`Mortality("/a)
`
`IOO
`
`l w
`
`24
`
`48
`
`72
`
`96
`
`a
`
`I20
`
`I44
`
`|68
`
`Time (h)
`
`Figure 1 The mortality in C57BL/6 mice given a single
`intraperitoneal dose of the glass powders. Administration of
`calcium phosphate glass containing increasing concentrations
`of silica increased the mortality depending on the amount of
`'0, 5, 10, 15 and 40 mol = calcium phosphate glasstCaO/P205 = 1)with the
`silica in the glass. (El) Omol; (4) 5mol; (A) 10 mol; (0)
`composition of 100 Ca(P0312 to x SlO2 in moles in which x = 0,5, 10, 15 or
`40 mol of slllca, and SIOZ = pure silica glass Itself.
`15 mol; (0)40 mol; (I) Sioz.
`
`
`0 mol
`5 mol
`10 mol
`15 mol
`40 mol
`Sio2
`
`5.9
`4.3
`3.9
`4.3
`8.3
`4.1
`
`3.2
`2.3
`3.0
`2.5
`3.1
`13.0
`
`Biomaterials 1992. Vol. 13 No. 3
`
`20f4
`2 of 4
`
`

`

`174
`
`
`Toxicity of silica-containing glass: M. Nagase et aI.
`
`silica enters the body in any other way than by ingestion,
`some type of toxicity almost invariably results". We
`showed that a calcium phosphate glass—ceramic con-
`taining 34.2 wt% of silica was lethal in C57BL/6 and A/I
`mice“. The LD50 of the silica containing glass—ceramic
`after intraperitoneal administration in C57BL/6 mice was
`750 mg/kg '(Ref. 4). The mice died from 2 to 6 days after
`administration of the glass—ceramic“. Significant footpad
`swelling occurred for a week after challenge in mice
`challenged with the glass—ceramic“. The lethality of the
`material administered weekly did not change during 5
`weeks‘. A special kind of inflammation, not an immuno—
`logical one“, plays an important
`role in the lethal
`reaction.
`
`The present study was undertaken to examine the
`intraperitoneal
`toxicity of calcium phosphate glass
`containing various concentrations of silica in C57BL/6
`mice. Calcium phosphate glasses containing large
`amounts of silica are extremely toxic. The Si“, Ca2+ and
`P5+ in water dissolved from the calcium phosphate glass
`depends on the amount of silica in the glasses, but the
`amounts of Ca2+ and P5+ were much lower than the
`amounts normally existing in serum. The dissolved silica
`(Si’Hl in this study may be monomeric or may not be
`highly polymerized“). It is suggested that the concentra-
`tion of monomeric or low molecular silicic anions
`determines the toxicity of the materials, but the total
`content of non-dissolved silica had no relation to its
`toxicity. In determining the biological consequences of
`dissolved or monomeric silica, what kind of reaction may
`play an important role in the lethal reaction will require
`further study.
`Under these circumstances it is interesting to speculate
`on the mechanism of the biological effects of dissolved or
`monomeric silica. There have been a great many studies
`to explore the pathogenesis of silicosisu'”. But almost
`all silicosis researchers studied the biological reactions
`of various forms of solid silica, e.g. crystalline silica
`(quartz, tridymite, cristobalite, coesite and stishovite)”,
`silica powder without an organophilic hydrophobic
`monolayer of hydrocarbon groups“, silica gel14 and the
`finest amorphous silica“. Nobody has investigated the
`toxicity of monomeric or low molecular silicic anions
`dissolved from composition materials. We showed in this
`study that there was no toxicity in pure silica (SiOz) glass
`or in calcium phosphate [Ca(P05)2] glass without silica.
`Monomeric silicic anions dissolved from silica-con-
`taining glasses may induce the toxicity. The difference in
`toxicity among the various forms of solid silica may
`depend on the amounts of monomeric silica dissolved
`from the silica. The difference in the mean time of death
`[6.0—68.0 h after administration in this study, 75.9 h after
`administration in our previous study‘] may depend on the
`different rates at which monomeric silica is dissolved
`from composition materials.
`Silica is also released from ‘bioglass‘, and the dissolved
`amount depends on the glass composition". It is hoped
`that future researchers and engineers will be mindful of
`this toxicity due to silica dissolved in calcium phosphate
`glass. Note also that we have not addressed any variation
`in sensitivity to silica with respect to age, sex, diet, route
`of exposure, or treatment regimen. These factors may also
`affect the 30-day mortality in mice.
`The marked physiological response at the high doses
`
`Biomaterials 1992, Vol. 13 No. 3
`
`of silica may well be symptomatic of the detrimental
`biochemical changes that follow silica exposure, even
`long after implantation, since glasses and ceramics are
`susceptible to both general corrosion and pitting attack in
`aqueous solutions, and silica is 20 times more soluble in
`organisms than in saline solution”. Several types of
`glass-ceramic in systems with calcium phosphate without
`silica have been developed” 19. That kind of glass—
`ceramic would be expected to be much better for implant
`systems than silica—containing glass—ceramics although
`the former have some disadvantages such as the weak
`mechanical
`strength in water and low chemical
`stability.
`
`ACKNOWLEDGEMENTS
`
`to Dr Hiroyasu Takeuchi,
`The authors are grateful
`Research and Development Center, Mitsubishi Material
`Co., Ltd for his assistance in measurements of grain size
`and surface area; and Mr Kiichi Oosawa, Department of
`Orthopaedic Surgery, Gunma University School of
`Medicine for his assistance in photography. This work
`was supported in part by Grant of Iapan Sports Medicine
`Foundation Inc. No. 1.
`
`REFERENCES
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`Hench, L.L., Splinter, R.]., Allen, W.C. and Greenlee,
`T.l(. Bonding mechanism at the interface of ceramic
`prosthetic materials. J. Biomed. Mater. Res. Symp.
`1971, 2, 117—141
`Blenke, B.A., Pfeil, E., Bromer, H. and Kas, H..,H
`Implantate aus Glas-Keramik in der Knochenchirurgie
`[Tierexperimentelle Untersuchungen]. Langenbechs Arch.
`Chir. Supp]. Forum 1973. 107—110
`Kitsugi, T., Yamamuro, T., Nakamura. T., Higashi. S.,
`Kakutani, Y., Hyakuna, K., Ito, S., Kokubo, T., 'I‘akagi.
`M. and Shibuya, T., Bone bonding behavior of three
`kinds of apatite containing glass ceramics, I. Biomed.
`Mater. Res. 1986, 20, 1295-1307
`Nagase, M., Shimizu, T., Chigira, M. and Udagawa, E..
`[An analytical study of the inflammation induced by a
`calcium phosphate ceramic,] Kitakanto Igaku 1987. 37,
`101—106
`Bradford. M.M., A rapid and sensitive method for the
`quantitation of microgram quantities of protein utilizing
`the principle of protein-dye binding, Anal. Biochem.
`1976, 72, 248—254
`Carlisle, E.M., Silicon: an essential element for the chick,
`Science 1972, 178, 619—621
`Schwartz, K. and Milne, D.B., Growth-promoting effects
`of silicon in rats, Nature 1972, 239, 333—334
`Schwartz, K., A bound form of silicon in glycosamino-
`glycans and polyuronides. Proc. Natl Acad. Sci. USA
`1973, 70, 1608—1612
`9 Michon, R., Sue, P. and Merinis, ]., Metabolisme de la
`Silice et des Silicates Inhales par l’Animal, Suiva a l’Aide
`de 313i. CR. Acad. Sci. 1956, 243, 2194—2195
`Abe, Y., Yoshikawa, Y., Naruse, A. and Saito, H, [Effect
`of SiOz additive on the rates of crystallization of
`Mg[P03]2 and Ca(P03]2 glasses.) I, Ceram. Soc. Jpn 1977,
`85, 151—153
`investigations on the
`Lungren, K.D., Experimental
`significance of the size of particles in the reaction of the
`
`10
`
`11
`
`3of4
`3 of 4
`
`

`

`Toxicity of silica-containing glass: M. Nagase et al.
`
`peritoneum to amorphous silica, Acta Med. Scand. 1953.
`145, 84-90
`Minova, K. F.. Respredelennie Kremniia v Organizme
`Belykh Krys Pri Eksperimental‘ nom Silikoze, Gig. Tr.
`Prof. Zabol. 1969, 13, 50—51
`Oghiso, Y. and Kubota, Y., Interleukin 1 production and
`accessory cell function of rat alveolar macrophages
`exposed to mineral dust particles, Microbiol. Immunol.
`1987, 31, 275-287
`Policard, A., Collet, A., Daniel-Moussard, H. and
`Pregemain, S., Sur les premiers stades des alterations
`experimentales du rein par l’acide silicique.. Etude au
`microscope electronique, ]. Ural. Med. Chir. 1960, 65,
`585—600
`Schepers, G.W.H., Hypertension due to inhaled sub-
`
`12
`
`13
`
`14
`
`15
`
`175
`
`16
`
`17
`
`18
`
`19
`
`'beicol. Appl. Pharmacol.
`
`micron amorphous silica,
`1959, 1, 487
`Stalder, K. and Stober, W., Haemolytic activity of
`suspensions of different silica modifications and inert
`dusts, Nature 1965. 207, 874—875
`Ravaglioli. A., Krajewski, A., Zini, Q. and Venturi, R.,
`Short and long range silicate release from doped bioglass
`into 199 medium, Biomaterials 1986, 7, 76—78
`Abe, Y.. Kasuga, T. and Hosono, H., Preparation of high-
`strength calcium phosphate glass-ceramics by uni-
`directional crystallization, ]. Am. Ceram. Soc. 1984, 67,
`142—144
`Abe, Y., Hosono, H. and Hosoe, M., Development of
`calcium phosphate glass—ceramics
`for surgical and
`dental use, Phosphorus & Sulfur 1987, 30, 337—340
`
`
`
`Biomaterials 1992, Vol. 13 No. 3
`
`4of4
`4 of 4
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket